Intra-tumour heterogeneity: a looking glass for cancer?

作者: Andriy Marusyk , Vanessa Almendro , Kornelia Polyak

DOI: 10.1038/NRC3261

关键词:

摘要: … pathways and that inactivate tumour suppressors 8 . However, unlike experimental tumours … Owing to sampling issues and differences in techniques in different pathology laboratories, …

参考文章(111)
Jen-Lan Tsao, Simon Tavaré, Reijo Salovaara, Jeremy R. Jass, Lauri A. Aaltonen, Darryl Shibata, Colorectal adenoma and cancer divergence. Evidence of multilineage progression. American Journal of Pathology. ,vol. 154, pp. 1815- 1824 ,(1999) , 10.1016/S0002-9440(10)65437-5
Bonnie E. Miller, Gloria H. Heppner, Todd Machemer, Martin Lehotan, Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Research. ,vol. 51, pp. 4378- 4387 ,(1991)
Michael Deininger, Resistance to imatinib: mechanisms and management. Journal of The National Comprehensive Cancer Network. ,vol. 3, pp. 757- 768 ,(2005) , 10.6004/JNCCN.2005.0045
I. Bozic, T. Antal, H. Ohtsuki, H. Carter, D. Kim, S. Chen, R. Karchin, K. W. Kinzler, B. Vogelstein, M. A. Nowak, Accumulation of driver and passenger mutations during tumor progression Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 18545- 18550 ,(2010) , 10.1073/PNAS.1010978107
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale, Insight into the heterogeneity of breast cancer through next-generation sequencing Journal of Clinical Investigation. ,vol. 121, pp. 3810- 3818 ,(2011) , 10.1172/JCI57088
P. Nowell, The clonal evolution of tumor cell populations Science. ,vol. 194, pp. 23- 28 ,(1976) , 10.1126/SCIENCE.959840
John M.L. Ebos, Christina R. Lee, William Cruz-Munoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel, Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis Cancer Cell. ,vol. 15, pp. 232- 239 ,(2009) , 10.1016/J.CCR.2009.01.021
Catherine Roche-Lestienne, Jean-Luc Laï, Stéphane Darré, Thierry Facon, Claude Preudhomme, A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. The New England Journal of Medicine. ,vol. 348, pp. 2265- 2266 ,(2003) , 10.1056/NEJMC035089